Montelukast Natrium Aurobindo

Montelukast, the active ingredient in Montelukast Natrium Aurobindo, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma, allergic rhinitis and exercise‑induced bronchoconstriction in patients who require maintenance therapy.

GNH USA supplies Montelukast Natrium Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast acts on the leukotriene pathway to control chronic airway inflammation and allergic symptoms. - Asthma (maintenance therapy): reduces the frequency of symptoms, nighttime awakenings and exacerbations. - Allergic rhinitis: alleviates nasal congestion, sneezing and itchy eyes caused by seasonal allergens. - Exercise‑induced bronchoconstriction: prevents bronchospasm triggered by physical activity, improving exercise tolerance.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Upper respiratory tract infection: transient symptoms. - Abdominal pain: occasional discomfort. - Cough: non‑productive. - Dyspepsia: mild indigestion. - Fatigue: occasional tiredness.

Serious or Rare Side Effects: - Neuropsychiatric events: agitation, depression, or suicidal thoughts. - Allergic reactions: rash, urticaria, or angioedema. - Hepatotoxicity: elevated liver enzymes. - Anaphylaxis: severe, rapid onset hypersensitivity. - Stevens‑Johnson syndrome: severe skin reaction. - Blood dyscrasias: rare cases of neutropenia or eosinophilia.

Before initiating therapy, consider the following safety measures. - Pregnancy: safety not established; discuss risks with a healthcare professional. - Breastfeeding: assess benefit‑risk ratio before use. - Hepatic impairment: use with caution; monitor liver function if indicated. - Concomitant psychiatric conditions: monitor for mood changes. - Pediatric use: dosage is weight‑based and prescribed by a clinician. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Montelukast may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Phenobarbital: may reduce montelukast plasma concentrations. - Rifampin: strong enzyme inducer that can lower efficacy.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): potential for additive neuropsychiatric effects. - Warfarin: monitor INR as rare reports suggest altered anticoagulation. - Other leukotriene modifiers: avoid concurrent use due to overlapping mechanisms.